Skip Navigation


Human Molecular Genetics Advance Access originally published online on March 14, 2006
Human Molecular Genetics 2006 15(8):1355-1364; doi:10.1093/hmg/ddl055
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Material
Right arrow All Versions of this Article:
15/8/1355    most recent
ddl055v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kock, N.
Right arrow Articles by Hanson, P. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kock, N.
Right arrow Articles by Hanson, P. I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Effects of genetic variations in the dystonia protein torsinA: identification of polymorphism at residue 216 as protein modifier

Norman Kock1,2,6, Teresa V. Naismith3, Heather E. Boston1,2, Laurie J. Ozelius4, David P. Corey5, Xandra O. Breakefield1,2 and Phyllis I. Hanson3,*

1Department of Neurology and 2Department of Radiology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA 02114, USA, 3Department of Cell Biology and Physiology, Washington University School of Medicine, 660 S. Euclid, Campus Box 8228, St Louis, MO 63110, USA, 4Molecular Genetics Department, Albert Einstein College of Medicine, New York, NY 10461, USA, 5Howard Hughes Medical Institute and Department of Neurobiology, Harvard Medical School, Boston, MA 02115, USA and 6Department of Neurology, University of Lübeck, Lübeck, Germany

* To whom correspondence should be addressed. Tel: +1 3147474233; Fax: +1 3143627463; Email: phanson22{at}wustl.edu

Received December 2, 2005; Accepted March 8, 2006

Four naturally occurring sequence variations have been found in the coding region of the DYT1 gene encoding torsinA. One of these, a 3 bp ({Delta}GAG) deletion, underlies dominantly inherited cases of early-onset torsion dystonia. Others, including a single nucleotide polymorphism that replaces aspartic acid (D) at residue 216 with histidine (H) in 12% of normal alleles and two other rare deletions, have not been clearly associated with disease. To gain insight into how these sequence variations affect torsinA, we used the structure of the related protein ClpB to provide a model of torsinA's AAA+ domain. Motifs important for ATP hydrolysis—sensor 1 and sensor 2—were identified, mutagenized and used to validate predictions of this model. Inspection revealed that the {Delta}GAG deletion associated with dystonia removes one residue from an {alpha}-helix in the C-terminal portion of the AAA+ domain. The resulting distortion in torsinA structure may underlie this mutant's known tendency to produce ER-derived inclusions as well as its proposed loss of function. The D/H polymorphism at residue 216 falls in the N-terminal portion of the AAA+ domain near the sensor 1 motif. Surprisingly, cells expressing torsinA with the polymorphic histidine developed inclusions similar to those associated with {Delta}GAG-torsinA, indicating that this change may also affect torsinA structure. Introducing H216 into {Delta}GAG-torsinA reduced its tendency to form inclusions, suggesting that the two changes offset each other. Our findings point to a structural basis for the defects associated with the disease-linked {Delta}GAG deletion in torsinA. They also suggest possible connections between the allelic polymorphism at residue 216 and the penetrance of DYT1 dystonia, as well as a possible role for this polymorphism in related disease states.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
L. M. Giles, J. Chen, L. Li, and L.-S. Chin
Dystonia-associated mutations cause premature degradation of torsinA protein and cell-type-specific mislocalization to the nuclear envelope
Hum. Mol. Genet., September 1, 2008; 17(17): 2712 - 2722.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
L. Zhu, J. O. Wrabl, A. P. Hayashi, L. S. Rose, and P. J. Thomas
The Torsin-family AAA+ Protein OOC-5 Contains a Critical Disulfide Adjacent to Sensor-II That Couples Redox State to Nucleotide Binding
Mol. Biol. Cell, August 1, 2008; 19(8): 3599 - 3612.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Kamm, H. Fischer, B. Garavaglia, S. Kullmann, M. Sharma, C. Schrader, K. Grundmann, C. Klein, I. Borggrafe, E. Lobsien, et al.
SUSCEPTIBILITY TO DYT1 DYSTONIA IN EUROPEAN PATIENTS IS MODIFIED BY THE D216H POLYMORPHISM
Neurology, June 3, 2008; 70(23): 2261 - 2262.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.